[PDF][PDF] Assessment of interleukin 17 and transforming growth factor-beta 1 in hepatitis C patients with disease progression.

WK Elbanan, SA Fathy, RA Ibrahim, MGA Hegazy - 2020 - msptm.org
Hepatitis C virus (HCV) infection in Egypt is the most serious health problem. Identifying
HCV-positive persons at high risk of early complications can help prioritize treatment …

IL17A gene polymorphism, serum IL17 and total IgE in Egyptian population with chronic HCV and hepatocellular carcinoma

MAER ELBassuoni, G Abd El Fatah, H Zaghla - Immunology Letters, 2015 - Elsevier
Background Chronic infections with HCV (CHC) induce a chronic inflammation which can
lead to liver fibrosis and subsequently cirrhosis. A recent study suggests a role of IL-17 …

Evaluation of serum fibrotic markers; CTGF, IL-17and TGF-β1 versus liver biopsy for detection of hepatic fibrosis in Egyptian patients with chronic hepatitis C

SK Kassim, SM Kamal, HH Shehata, MM Salib… - Meta Gene, 2017 - Elsevier
Abstract Objectives Hepatitis C virus (HCV) infection in Egypt is the most serious health
problem, where 10%–15% of the population is infected. The severity of the disease and …

Role of interleukin-17 in the development of hepatocellular carcinoma in hepatitis C virus liver cirrhosis

A Elsayed, E Mohammed, N Ali… - … University Medical Journal, 2015 - journals.ekb.eg
Background: The level of Interleukin-17 (IL-17) have been found in increased frequencies
within certain tumors. However, their role in cancer biology remains controversial. This study …

Diagnostic role of Golgi protein 73 and IL-17 in Egyptian cirrhotic rather than hepatocellular carcinoma patients

RA Nawaya, NM Abdel-Hamid… - Journal of Applied …, 2016 - japsonline.com
Hepatocellular carcinoma (HCC) is the most common primary liver malignancy and the third
cause of cancer mortality worldwide. This study aimed to pursue changes in serum …